Turkey · Delayed Price · Currency is TRY IST:MEDTR Statistics
Total Valuation
IST:MEDTR has a market cap or net worth of TRY 3.57 billion. The enterprise value is 3.15 billion.
| Market Cap | 3.57B |
| Enterprise Value | 3.15B |
Important Dates
The next estimated earnings date is Monday, August 10, 2026.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | Jul 29, 2026 |
Share Statistics
IST:MEDTR has 119.00 million shares outstanding.
| Current Share Class | 95.38M |
| Shares Outstanding | 119.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 79.41% |
| Owned by Institutions (%) | 5.16% |
| Float | 24.50M |
Valuation Ratios
The trailing PE ratio is 130.66.
| PE Ratio | 130.66 |
| Forward PE | n/a |
| PS Ratio | 1.31 |
| PB Ratio | 1.13 |
| P/TBV Ratio | 1.17 |
| P/FCF Ratio | 8.64 |
| P/OCF Ratio | 5.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.69, with an EV/FCF ratio of 7.62.
| EV / Earnings | 115.27 |
| EV / Sales | 1.15 |
| EV / EBITDA | 12.69 |
| EV / EBIT | 44.96 |
| EV / FCF | 7.62 |
Financial Position
The company has a current ratio of 3.58, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.58 |
| Quick Ratio | 2.28 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.08 |
| Interest Coverage | 2.14 |
Financial Efficiency
Return on equity (ROE) is 1.03% and return on invested capital (ROIC) is 3.42%.
| Return on Equity (ROE) | 1.03% |
| Return on Assets (ROA) | 1.66% |
| Return on Invested Capital (ROIC) | 3.42% |
| Return on Capital Employed (ROCE) | 2.75% |
| Weighted Average Cost of Capital (WACC) | 7.36% |
| Revenue Per Employee | 3.43M |
| Profits Per Employee | 34,372 |
| Employee Count | 796 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 3.38 |
Taxes
| Income Tax | -59.47M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.31% in the last 52 weeks. The beta is 0.41, so IST:MEDTR's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -1.31% |
| 50-Day Moving Average | 29.32 |
| 200-Day Moving Average | 29.63 |
| Relative Strength Index (RSI) | 50.29 |
| Average Volume (20 Days) | 1,058,253 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IST:MEDTR had revenue of TRY 2.73 billion and earned 27.36 million in profits.
| Revenue | 2.73B |
| Gross Profit | 792.27M |
| Operating Income | 90.61M |
| Pretax Income | -30.63M |
| Net Income | 27.36M |
| EBITDA | 259.64M |
| EBIT | 90.61M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 480.09 million in cash and 31.54 million in debt, with a net cash position of 448.55 million or 3.77 per share.
| Cash & Cash Equivalents | 480.09M |
| Total Debt | 31.54M |
| Net Cash | 448.55M |
| Net Cash Per Share | 3.77 |
| Equity (Book Value) | 3.17B |
| Book Value Per Share | n/a |
| Working Capital | 1.37B |
Cash Flow
In the last 12 months, operating cash flow was 615.74 million and capital expenditures -201.96 million, giving a free cash flow of 413.78 million.
| Operating Cash Flow | 615.74M |
| Capital Expenditures | -201.96M |
| Depreciation & Amortization | 169.02M |
| Net Borrowing | -16.66M |
| Free Cash Flow | 413.78M |
| FCF Per Share | 3.48 |
Margins
Gross margin is 28.98%, with operating and profit margins of 3.31% and 1.00%.
| Gross Margin | 28.98% |
| Operating Margin | 3.31% |
| Pretax Margin | -1.12% |
| Profit Margin | 1.00% |
| EBITDA Margin | 9.50% |
| EBIT Margin | 3.31% |
| FCF Margin | 15.13% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.84%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 0.84% |
| Dividend Growth (YoY) | 135.01% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 138.03% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.84% |
| Earnings Yield | 0.77% |
| FCF Yield | 11.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 22, 2022. It was a forward split with a ratio of 3.5.
| Last Split Date | Feb 22, 2022 |
| Split Type | Forward |
| Split Ratio | 3.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |